The annual health benefit enrollment period for plan year 2022 is September 27 through October 22, 2021. This is when you can make changes for next year, including changing your plan. health plan, coverage levels or add / remove certain dependents for an effective date of January 1, 2022.
Visit the Health page to find pricing and other information on your 2022 health benefits. There are downloadable 2022 health benefit decision guides and the 2022 open enrollment overview video that reviews the 2022 health benefits. significant changes. Printed decision guides are also being mailed to retirees and employers participating in the group health insurance program this week.
Health Benefits Webinars
The Employee Trust Fund Department is hosting a series of webinars for members to learn about health benefits and connect with health plans and other providers during open registration. Webinars are designed to give you better access to information than an in-person benefits lounge. Plus, you can participate in the safety and comfort of your home or workplace.
Please click on the links below for more details, including webinar dates and times and to register. Sessions last one hour and are offered at different times of the week.
- Open-Ended Health Webinars – Learn more about health, dental and pharmaceutical benefits, and get your questions answered by the ETF’s benefit specialists.
- Q&A Webinars for Open Enrollment Providers – Learn about the health plans and available providers (i.e. Aspirus, Delta, Navitus, etc.) and get your questions answered by the supplier’s staff.
Sessions will be moderated to help answer as many questions as possible. Please do not ask questions that include personally identifiable information or protected health information.
All members who participate or are eligible to participate in the group health insurance program are encouraged to register for these webinars. Please contact the ETF for any accessibility issues.
The ETF will not be attending in-person benefit shows this year due to the COVID-19 pandemic.